Loading...
OTCM
AFIB
Market cap59kUSD
Jul 07, Last price  
0.00USD
1D
0.00%
1Q
-94.88%
IPO
-99.99%
Name

Acutus Medical Inc

Chart & Performance

D1W1MN
P/E
P/S
0.00
EPS
Div Yield, %
Shrs. gr., 5y
1.65%
Rev. gr., 5y
48.03%
Revenues
20m
+181.37%
2,166,0002,836,0008,464,00017,263,00016,363,0007,164,00020,157,000
Net income
-10m
L-88.31%
-47,907,000-119,307,000-101,981,000-123,360,000-39,616,000-81,663,000-9,547,000
CFO
-32m
L-50.23%
-33,780,000-55,986,000-85,169,000-99,682,000-85,032,000-63,608,000-31,660,000

Profile

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
IPO date
Aug 06, 2020
Employees
225
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
20,157
181.37%
7,164
-56.22%
16,363
-5.21%
Cost of revenue
19,144
13,783
60,063
Unusual Expense (Income)
NOPBT
1,013
(6,619)
(43,700)
NOPBT Margin
5.03%
Operating Taxes
63
82
Tax Rate
NOPAT
1,013
(6,682)
(43,782)
Net income
(9,547)
-88.31%
(81,663)
106.14%
(39,616)
-67.89%
Dividends
Dividend yield
Proceeds from repurchase of equity
(82)
(44)
BB yield
1.40%
0.13%
Debt
Debt current
7,962
3,300
319
Long-term debt
30,997
39,858
42,959
Deferred revenue
Other long-term liabilities
12
Net debt
24,940
20,755
(27,669)
Cash flow
Cash from operating activities
(31,660)
(63,608)
(85,032)
CAPEX
(219)
(3,983)
Cash from investing activities
22,149
58,555
104,750
Cash from financing activities
(2,891)
(2,664)
(12,116)
FCF
3,175
16,293
(53,385)
Balance
Cash
14,019
22,403
70,447
Long term investments
500
Excess cash
13,011
22,045
70,129
Stockholders' equity
(610,262)
(600,814)
(519,154)
Invested Capital
634,434
639,132
632,402
ROIC
0.16%
ROCE
4.19%
EV
Common stock shares outstanding
29,768
29,095
28,471
Price
0.06
-72.76%
0.20
-82.44%
1.15
-66.28%
Market cap
1,637
-72.13%
5,874
-82.06%
32,742
-66.49%
EV
26,577
26,629
5,073
EBITDA
2,040
(5,745)
(36,571)
EV/EBITDA
13.03
Interest
5,758
5,655
5,149
Interest/NOPBT
568.41%